Adverum

ADVM NASDAQ
11.79
+0.97
+8.96%
交易中 15:10 06/17 EDT
开盘
10.91
昨收
10.82
最高
11.83
最低
10.91
成交量
35.76万
成交均量(3M)
64.64万
52周最高
11.83
52周最低
2.620
换手率
0.56%
市值
7.48亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Adverum ADVM股票价格,Adverum股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases. Adverum has a robust pipeline that includes product candidates designed to treat rare diseases alpha-1 antitrypsin (A1AT) deficiency and hereditary angioedema (HAE) as well as wet age-related macular degeneration (wAMD). Leveraging a next-generation adeno-associated virus (AAV)-based directed evolution platform, Adverum generates product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. It has collaboration agreements with Regeneron Pharmaceuticals to research, develop, and commercialize gene therapy products for ophthalmic diseases and Editas Medicine to explore the delivery of genome editing medicines for the treatment of inherited retinal diseases. Its core capabilities include clinical development and in-house manufacturing, specifically in process development and assay development.
展开 >

最近浏览

名称
价格
涨跌幅